BIOREM INC (BRM.CA) Stock Fundamental Analysis
TSX-V:BRM - CA09068G1046 - Common Stock
2.06 CAD
-0.03 (-1.44%)
We assign a fundamental rating of 8 out of 10 to BRM. BRM was compared to 24 industry peers in the Commercial Services & Supplies industry. BRM has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. BRM has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! This makes BRM very considerable for value and growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year BRM was profitable.
In the past year BRM had a positive cash flow from operations.
Each year in the past 5 years BRM has been profitable.
Each year in the past 5 years BRM had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 12.64%, BRM belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
The Return On Equity of BRM (30.95%) is better than 91.67% of its industry peers.
BRM's Return On Invested Capital of 26.24% is amongst the best of the industry. BRM outperforms 100.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BRM is significantly above the industry average of 6.97%.
The last Return On Invested Capital (26.24%) for BRM is above the 3 year average (25.13%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.64% | ||
| ROE | 30.95% | ||
| ROIC | 26.24% |
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
1.3 Margins
BRM has a better Profit Margin (7.31%) than 83.33% of its industry peers.
BRM's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 10.65%, BRM is in the better half of the industry, outperforming 79.17% of the companies in the same industry.
In the last couple of years the Operating Margin of BRM has grown nicely.
BRM has a Gross Margin of 26.49%. This is comparable to the rest of the industry: BRM outperforms 54.17% of its industry peers.
In the last couple of years the Gross Margin of BRM has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.65% | ||
| PM (TTM) | 7.31% | ||
| GM | 26.49% |
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
2. Health
2.1 Basic Checks
BRM has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
BRM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BRM has been reduced compared to 5 years ago.
The debt/assets ratio for BRM has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.29 indicates that BRM is not in any danger for bankruptcy at the moment.
The Altman-Z score of BRM (4.29) is better than 95.83% of its industry peers.
BRM has a debt to FCF ratio of 0.91. This is a very positive value and a sign of high solvency as it would only need 0.91 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.91, BRM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
A Debt/Equity ratio of 0.30 indicates that BRM is not too dependend on debt financing.
The Debt to Equity ratio of BRM (0.30) is better than 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 0.91 | ||
| Altman-Z | 4.29 |
ROIC/WACC3.36
WACC7.82%
2.3 Liquidity
BRM has a Current Ratio of 1.91. This is a normal value and indicates that BRM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.91, BRM belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
A Quick Ratio of 1.66 indicates that BRM should not have too much problems paying its short term obligations.
BRM has a better Quick ratio (1.66) than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.66 |
3. Growth
3.1 Past
The earnings per share for BRM have decreased strongly by -13.75% in the last year.
BRM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.08% yearly.
BRM shows a strong growth in Revenue. In the last year, the Revenue has grown by 51.00%.
The Revenue has been growing by 12.63% on average over the past years. This is quite good.
EPS 1Y (TTM)-13.75%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-89.13%
Revenue 1Y (TTM)51%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-20.07%
3.2 Future
The Earnings Per Share is expected to grow by 33.77% on average over the next years. This is a very strong growth
BRM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.41% yearly.
EPS Next Y5.26%
EPS Next 2Y33.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.36%
Revenue Next 2Y14.41%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.12 indicates a correct valuation of BRM.
Based on the Price/Earnings ratio, BRM is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
BRM's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.90.
A Price/Forward Earnings ratio of 5.88 indicates a rather cheap valuation of BRM.
BRM's Price/Forward Earnings ratio is rather cheap when compared to the industry. BRM is cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BRM to the average of the S&P500 Index (22.52), we can say BRM is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.12 | ||
| Fwd PE | 5.88 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRM is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, BRM is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.09 | ||
| EV/EBITDA | 5.91 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BRM does not grow enough to justify the current Price/Earnings ratio.
BRM has an outstanding profitability rating, which may justify a higher PE ratio.
BRM's earnings are expected to grow with 33.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.3
PEG (5Y)N/A
EPS Next 2Y33.77%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for BRM!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX-V:BRM (9/2/2025, 7:00:00 PM)
2.06
-0.03 (-1.44%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.16%
Inst Owner ChangeN/A
Ins Owners1.98%
Ins Owner ChangeN/A
Market Cap33.21M
Analysts84.44
Price Target4.08 (98.06%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-9.09%
EPS NY rev (3m)-9.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.85%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.12 | ||
| Fwd PE | 5.88 | ||
| P/S | 0.79 | ||
| P/FCF | 8.09 | ||
| P/OCF | 7.9 | ||
| P/B | 3.34 | ||
| P/tB | 3.34 | ||
| EV/EBITDA | 5.91 |
EPS(TTM)0.17
EY8.25%
EPS(NY)0.35
Fwd EY17%
FCF(TTM)0.25
FCFY12.35%
OCF(TTM)0.26
OCFY12.65%
SpS2.61
BVpS0.62
TBVpS0.62
PEG (NY)2.3
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 12.64% | ||
| ROE | 30.95% | ||
| ROCE | 34.64% | ||
| ROIC | 26.24% | ||
| ROICexc | 59.83% | ||
| ROICexgc | 59.83% | ||
| OM | 10.65% | ||
| PM (TTM) | 7.31% | ||
| GM | 26.49% | ||
| FCFM | 9.73% |
ROA(3y)9.17%
ROA(5y)8.76%
ROE(3y)32.25%
ROE(5y)35.65%
ROIC(3y)25.13%
ROIC(5y)23.46%
ROICexc(3y)41.23%
ROICexc(5y)N/A
ROICexgc(3y)41.23%
ROICexgc(5y)N/A
ROCE(3y)33.17%
ROCE(5y)30.97%
ROICexcg growth 3Y-30.69%
ROICexcg growth 5YN/A
ROICexc growth 3Y-30.69%
ROICexc growth 5YN/A
OM growth 3Y7.19%
OM growth 5YN/A
PM growth 3Y15.35%
PM growth 5YN/A
GM growth 3Y1.79%
GM growth 5Y2.67%
F-Score6
Asset Turnover1.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 0.91 | ||
| Debt/EBITDA | 0.6 | ||
| Cap/Depr | 18.68% | ||
| Cap/Sales | 0.24% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 83.68% | ||
| Profit Quality | 133.16% | ||
| Current Ratio | 1.91 | ||
| Quick Ratio | 1.66 | ||
| Altman-Z | 4.29 |
F-Score6
WACC7.82%
ROIC/WACC3.36
Cap/Depr(3y)93.69%
Cap/Depr(5y)79.96%
Cap/Sales(3y)1.3%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.75%
EPS 3Y32.08%
EPS 5YN/A
EPS Q2Q%-89.13%
EPS Next Y5.26%
EPS Next 2Y33.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51%
Revenue growth 3Y15.2%
Revenue growth 5Y12.63%
Sales Q2Q%-20.07%
Revenue Next Year-1.36%
Revenue Next 2Y14.41%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.31%
EBIT growth 3Y23.48%
EBIT growth 5YN/A
EBIT Next Year38.31%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.49%
FCF growth 3Y-3.66%
FCF growth 5Y6.73%
OCF growth 1Y41.83%
OCF growth 3Y-0.86%
OCF growth 5Y7.83%